Arthur Caplan

Arthur Caplan
Name	Arthur Caplan
Birth date	1950
Birth place	New York City, New York, United States
Occupation	Bioethicist, Professor, Author
Employer	New York University Grossman School of Medicine
Known for	Clinical ethics, public health ethics, organ transplantation ethics, human subjects research ethics

Arthur Caplan Arthur Caplan is an American bioethicist and scholar known for leadership in clinical ethics, public health ethics, and biomedical policy. He has held senior academic positions, advised governmental and international bodies, and authored numerous articles and books on ethical issues related to medicine, biotechnology, and research. Caplan's work spans organ transplantation, human subjects research, pandemic ethics, and emerging technologies, engaging with policymakers, physicians, and the public.

Early life and education

Caplan was born in New York City and raised in Brooklyn and Queens, New York. He completed undergraduate studies at Yeshiva University before earning a Ph.D. in the history and philosophy of science from Brandeis University. He trained in philosophy of science linked to scholars at Harvard University and engaged with research communities at Massachusetts Institute of Technology and Boston University. Early mentors included figures associated with American Philosophical Association-affiliated networks and scholars connected to the National Institutes of Health research environment.

Academic and professional career

Caplan began his academic career at institutions such as Tufts University and the University of Massachusetts Amherst, later joining the faculty of the University of Pennsylvania where he was associated with the Perelman School of Medicine. He served as founding director of the Center for Bioethics at University of Pennsylvania before moving to the University of Minnesota to direct the Center for Bioethics. He was later appointed to roles at the University of Pennsylvania Health System and served on panels convened by the Institute of Medicine (now the National Academy of Medicine). Caplan became head of the Division of Medical Ethics at the University of Pennsylvania School of Medicine and subsequently joined the New York University Grossman School of Medicine as a professor and head of the Division of Medical Ethics. He has taught and consulted with organizations including the World Health Organization, Centers for Disease Control and Prevention, Food and Drug Administration, and the World Bank.

Bioethics research and contributions

Caplan's research addresses ethical questions in organ transplantation, human experimentation, genetic engineering, and pandemic response. He published influential analyses on organ allocation ethics linked to practices at the United Network for Organ Sharing and ethical standards reflected in policy documents by the Department of Health and Human Services. His work on human subjects helped shape debates surrounding the Common Rule and regulatory frameworks developed by the Office for Human Research Protections. Caplan contributed to ethics discussions about experimental therapies during outbreaks such as the Ebola virus epidemic in West Africa and the COVID-19 pandemic, engaging with guidance from the World Health Organization and the Centers for Disease Control and Prevention. He examined ethical implications of novel technologies linked to CRISPR, stem cell research policies influenced by the National Institutes of Health, and issues at the intersection of bioethics and law as seen in rulings from the United States Supreme Court and debates over statutes like the Bayh–Dole Act. Caplan emphasized equitable access themes that interact with programs run by the Bill & Melinda Gates Foundation and policy initiatives associated with the National Academies of Sciences, Engineering, and Medicine.

Public engagement and media presence

Caplan has been a prominent public intellectual, writing for outlets such as The New York Times, The Washington Post, and The Atlantic, and appearing on broadcasts produced by National Public Radio, BBC News, and CNN. He has contributed op-eds and commentary to publications including Science, Nature, and The Lancet, frequently offering analysis during public health crises like the H1N1 influenza pandemic and the COVID-19 pandemic. Caplan has testified before committees of the United States Congress and advised advisory panels for the World Health Organization and the Food and Drug Administration. He has collaborated with institutional ethics committees at hospitals such as Mount Sinai Health System and NewYork-Presbyterian Hospital, and engaged in public debates alongside figures from Johns Hopkins University, Harvard Medical School, and the Kaiser Family Foundation.

Awards and honors

Caplan has received honors from academic and policy organizations, including recognition by the American Society for Bioethics and Humanities and awards connected to the Hastings Center and the Robert Wood Johnson Foundation. He has been elected to memberships and advisory roles within the National Academy of Medicine and has received honorary degrees and distinguished professorships at institutions such as Yeshiva University and New York University. His work has been cited in reports by the World Health Organization and in policy briefs for the Centers for Disease Control and Prevention.

Selected controversies and criticisms

Caplan's forthright public stances have sometimes provoked controversy. Critics in academic and activist circles at institutions like Harvard University and Columbia University have disputed his positions on organ markets, arguing against commodification and raising concerns echoed by advocacy groups including Physicians for Human Rights and Amnesty International. His advocacy for utilitarian allocation frameworks during pandemics drew critique from scholars associated with Georgetown University and the University of Chicago who favored alternative egalitarian approaches. Debates with commentators at The New Yorker and The New York Review of Books questioned his media statements on experimental therapeutics during outbreaks such as the Ebola virus epidemic in West Africa and the COVID-19 pandemic. Legal scholars at the American Bar Association and plaintiffs in litigation referenced ethical positions he articulated during policy disputes over research oversight and vaccine allocation.

Category:Bioethicists Category:New York University faculty Category:1950 births Category:Living people